Effectiveness of I and II line chemo-targeted therapy according to the scheme Oxaliplatin Capecitabine Bevacizumab (XELOX BVZ) in patients with metastatic colorectal cancer (mCRC)

Smagulova, K.; Chichua, N.; Arzykulov, Zhetkergen; Yessentayeva, Suriya; Abdrakhmanov, R.; Tumanova, Assel; Mukanova, Sholpan; Мoldasheva, F.

doi:10.15208/mhsj.2011.151

Search citation statements

Order By: Relevance

Paper Sections

Select...

этапы становления и основные достижения отделения химиотерап...1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Показатели однои двухлетней выживаемости составили 84,8 и 77,1%, соответственно. Была проведена оценка значимости гиперэкспрессией Her2/neu у больных КРР, из 42 обследованных больных только в 3 (7,1%) случаях была выявлена гиперэкспрессия Her2/neu, коррелировавшая с низкой выживаемостью: все эти больные умерли, не прожив одного года [5].…”

Section: этапы становления и основные достижения отделения химиотерап...unclassified

Stages of formation and main achievements of the Chemotherapy Department of Kazakh Research Institute of Oncology and Radiology

Kaidarova

Chichua

Smagulova

et al. 2020

Onkol. radiol. Kaz.

View full text Add to dashboard Cite

The article talks about the Chemotherapy Department of the Kazakh Research Institute of Oncology and Radiology (KazIOR), which is an important part of cancer patients’ treatment in the Republic of Kazakhstan. The roll-out of clinical chemotherapy as one of the main cancer treatment methods was initiated by Professor S.N. Nugmanov, the director of KazIOR, in 1963, three years after the Institute was established. In addition to clinical activities, the department staff conducts research, participates in clinical trials, provides consulting and methodological assistance in consolidating the national chemotherapy service, and develops national clinical cancer treatment guidelines.

show abstract

Section: этапы становления и основные достижения отделения химиотерап...unclassified

Stages of formation and main achievements of the Chemotherapy Department of Kazakh Research Institute of Oncology and Radiology

Kaidarova

Chichua

Smagulova

et al. 2020

Onkol. radiol. Kaz.

View full text Add to dashboard Cite

show abstract

Effectiveness of I and II line chemo-targeted therapy according to the scheme Oxaliplatin Capecitabine Bevacizumab (XELOX BVZ) in patients with metastatic colorectal cancer (mCRC)

Cited by 1 publication

References 0 publications

Stages of formation and main achievements of the Chemotherapy Department of Kazakh Research Institute of Oncology and Radiology

Stages of formation and main achievements of the Chemotherapy Department of Kazakh Research Institute of Oncology and Radiology

Contact Info

Product

Resources

About